A growing obesity crisis is emerging as a major business concern in the Philippines, with experts warning that its impact extends far beyond healthcare and into workplace productivity, employee well-being, and economic performance.
Obesity and its related diseases are imposing a heavy economic toll on the Philippines, reshaping both health-care priorities and demand for new treatments such as semaglutide.